グレカプレビル/ピブレンタスビル治療はゲノタイプ2型C型慢性肝疾患に対するソフォスブビル+リバビリン治療のウイルス学的無効例に有効である
Digital data available（Japan Link Center）
Begin reading now
CiNii Research
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- 渡邊 俊司三浦 光一森本 直樹室久 俊光田野 茂夫田原 利行岡村 幸重深谷 幸祐佐藤 隆飯島 誠沼尾 規且廣澤 拓也倉田 秀一村山 梢上原 慶太吉住 博明中澤 克行菅谷 仁五家 里栄野本 弘章高岡 良成津久井 舞未子礒田 憲夫山本 博徳
- Author Heading
- Alternative Title
- Efficacy and Safety of Glecaprevir/Pibrentasvir Combination Therapy for Patients with Genotype 2 Chronic Hepatitis C Infection Who Failed HCV Eradication by SOF+RBV Treatment
- Periodical title
- 肝臓
- No. or year of volume/issue
- 60(2):2019.2
- Volume
- 60
- Issue
- 2
- Pages
- 77-79